Bayer, which acquired Monsanto in 2018, has recently broken its winning trial record with a number of jury verdicts against it
Published 11/18/23
Read Mor
Published 11/18/23
Rocio Fabbro
Bayer’s Monsanto was ordered to pay more than $1.5 billion Friday over claims its patented weed-killer, Roundup, was linked to users’ cancer, Bloomberg reported.
James Draeger, Valerie Gunther and Dan Anderson were each awarded a total of $61.1 million in actual damages and $500 million each in punitive damages by jurors in state court in Jefferson City, Missouri.
The three people alleged that their non-Hodgkin’s lymphomas — a type of cancer that begins in your lymphatic system, part of the body’s immune system — were caused by years of using Roundup while gardening.
Late last month, a Missouri state court jury awarded $1.25 million to a man claiming he developed cancer from exposure to Roundup, Courtroom View Network reported. Bayer attributes its winning trial record in litigation over its herbicide to confidence that its “products can be used safely and are not carcinogenic,” the company told the outlet.
Bayer’s Monsanto was ordered to pay more than $1.5 billion Friday over claims its patented weed-killer, Roundup, was linked to users’ cancer, Bloomberg reported.
James Draeger, Valerie Gunther and Dan Anderson were each awarded a total of $61.1 million in actual damages and $500 million each in punitive damages by jurors in state court in Jefferson City, Missouri.
The three people alleged that their non-Hodgkin’s lymphomas — a type of cancer that begins in your lymphatic system, part of the body’s immune system — were caused by years of using Roundup while gardening.
Late last month, a Missouri state court jury awarded $1.25 million to a man claiming he developed cancer from exposure to Roundup, Courtroom View Network reported. Bayer attributes its winning trial record in litigation over its herbicide to confidence that its “products can be used safely and are not carcinogenic,” the company told the outlet.
In 2020, Bayer agreed to pay $10.5 billion to settle claims that use of Roundup led to cancer in nearly 100,000 people.
Josh Edelson/AFP via Getty Images
Bayer recently won nine cases against it over the herbicide, but has, of late, seen a series of jury verdicts finding that it is linked to customers' cancer, according to Bloomberg.
Bayer closed its $63 billion acquisition of Monsanto in 2018 — and has been plagued with debt and legal issues over Roundup since. The most active ingredient in the herbicide is glyphosate, which kills most plants it comes into contact with and has been found to “probably” cause cancer in humans, according to the International Agency for Research on Cancer.
Bayer recently won nine cases against it over the herbicide, but has, of late, seen a series of jury verdicts finding that it is linked to customers' cancer, according to Bloomberg.
Bayer closed its $63 billion acquisition of Monsanto in 2018 — and has been plagued with debt and legal issues over Roundup since. The most active ingredient in the herbicide is glyphosate, which kills most plants it comes into contact with and has been found to “probably” cause cancer in humans, according to the International Agency for Research on Cancer.
Read Mor
Roundup Deal Continues to Drag on Bayer, as CEO Weighs Splitting Company
Leaked Document Shows Europe May Reauthorize Controversial Weed Killer Glyphosate for Use
In 2020, Bayer agreed to pay $10.5 billion to settle claims that use of the weed-killer led to cancer in nearly 100,000 people.
Roundup has since been the subject of thousands of lawsuits, with Friday’s $1.5 billion settlement among the largest damages awarded against a U.S. corporate defendant this year, according to Bloomberg.
Leaked Document Shows Europe May Reauthorize Controversial Weed Killer Glyphosate for Use
In 2020, Bayer agreed to pay $10.5 billion to settle claims that use of the weed-killer led to cancer in nearly 100,000 people.
Roundup has since been the subject of thousands of lawsuits, with Friday’s $1.5 billion settlement among the largest damages awarded against a U.S. corporate defendant this year, according to Bloomberg.
No comments:
Post a Comment